Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 HKD | +2.40% | +3.56% | +34.88% |
04-09 | Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma | MT |
04-01 | Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps | MT |
Business Summary
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Anti-viral Drugs
88.7
%
| 3,624 | 83.2 % | 6,166 | 88.7 % | +70.17% |
Other Medical Products
4.1
%
| 323 | 7.4 % | 286 | 4.1 % | -11.54% |
Cardiovascular Drugs
2.9
%
| 175 | 4.0 % | 203 | 2.9 % | +16.55% |
Endocrine and Metabolic Drugs
2.6
%
| 132 | 3.0 % | 181 | 2.6 % | +37.45% |
Anti-infectives Drugs
1.7
%
| 101 | 2.3 % | 118 | 1.7 % | +16.52% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 4,355 | 100.0 % | 6,956 | 100.0 % | +59.72% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Cai Jiang
CEO | Chief Executive Officer | 42 | 03/05/15 |
Qiang Zhang
DFI | Director of Finance/CFO | 49 | 22/02/18 |
Hao Chen
BRD | Director/Board Member | 49 | 31/10/09 |
Shuang Li
BRD | Director/Board Member | 43 | 06/08/05 |
Dan Jin Wang
BRD | Director/Board Member | 54 | 26/02/06 |
Qi Yun Peng
IRC | Investor Relations Contact | 34 | 30/06/16 |
Wai Chiu Wong
SEC | Corporate Secretary | 69 | 24/02/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Xin Fa Tang
CHM | Chairman | 54 | 03/05/15 |
Jun Cai Jiang
CEO | Chief Executive Officer | 42 | 03/05/15 |
Dan Jin Wang
BRD | Director/Board Member | 54 | 26/02/06 |
Zhong Hua Luo
BRD | Director/Board Member | 40 | 15/06/17 |
Shuang Li
BRD | Director/Board Member | 43 | 06/08/05 |
Sheng Chao Wang
BRD | Director/Board Member | 41 | 30/04/12 |
Jin Long Tang
CHM | Chairman | 55 | 30/06/01 |
Ling Xiang
BRD | Director/Board Member | 43 | 04/06/20 |
Xue Chen Li
BRD | Director/Board Member | 47 | 24/09/20 |
Hao Chen
BRD | Director/Board Member | 49 | 31/10/09 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 226,200,000 | 0 | 0 | 27.70 % |
Stock B | 1 | 653,767,700 | 243,709,300 ( 37.28 %) | 0 |
Company contact information
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
No. 38, Binjiang Road Yidu
443300, Yichang
+
http://cj.hec.cn/en/index.aspxSector
Sales per Business
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.88% | 1.44B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 1558 Stock
- Company YiChang HEC ChangJiang Pharmaceutical Co., Ltd.